Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

Different protein lifetimes may separate -driven cell recycling from

In , a may leave cell recycling active after extra growth activity fades, allowing feeding with less altered-cell growth. Responses fading together, or changing lifetime without changing this separation, would reject the hypothesis.

Stage of verification

  1. Hypothesis published2026-10-06
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionGut and microbiome

Biological function

The lysosomal programme supports autophagic breakdown and recycling of damaged cellular components. The hypothesis examines this function alongside the regulation of cell growth, with intestinal organoids specified as the experimental model.Autophagic component recycling

Direction

A double ring marks the main placement where a group contains several values.

Lens
Differential protein turnover
Goal
Устойчивый запас до обращения пользы миметика во вред
Competing hypotheses
3
Published
2026-10-06
As a hypothesis
8 / 10Clarity of mechanism
6 / 10Few extra conditions
10 / 10Completeness of the answer
6 / 10Novelty of the idea
10 / 10Few new entities
8 / 10Decisive experiment
3 / 10Silver-bullet potential
4 / 10Support from research

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Metabolism and energy

    The cellular process of breaking down and recycling damaged components

    Where this hypothesis acts after a short -mimetic pulse and during feeding resumption

    Hypotheses on this target 2
    AutophagyInhibition. Hypotheses on this target 0Activation. Hypotheses on this target 11Function preservation. Hypotheses on this target 11Supplementation. Hypotheses on this target 0Feedback restoration. Hypotheses on this target 0Direct measurement. Hypotheses on this target 0
    • Inhibition
    • Activation1
    • Function preservation1
    • Supplementation
    • Feedback restoration
    • Direct measurement

    What is proposed

    Function preservation

    Sustain elevated through the resumption of feeding

    With whatSmall molecule

    HowApply a short -mimetic pulse and resume feeding while the -induced lysosomal machinery remains functional after additional activity subsides

    Possible result

    Possible continued recycling of damaged components and functional benefit with less growth of altered cells

    From the recordПосле спермидинового импульса обнаружится интервал, в котором аутофагический поток остаётся повышенным, а дополнительная активность MYC уже исчезла.

  2. Regulatory protein

    A protein that regulates growth

    Where this hypothesis actsAltered cells after a -mimetic pulse; proposed testing in

    Hypotheses on this target 1
    MYCInhibition. Hypotheses on this target 0Activation. Hypotheses on this target 0Lower level. Hypotheses on this target 11Higher level. Hypotheses on this target 0Protection from degradation. Hypotheses on this target 0Function restoration. Hypotheses on this target 0Function preservation. Hypotheses on this target 0
    • Inhibition
    • Activation
    • Lower level1
    • Higher level
    • Protection from degradation
    • Function restoration
    • Function preservation

    What is proposed

    Lower level

    Allow additional activity to subside before feeding resumes

    With whatChange of environment or regimen

    HowResume feeding after the growth pulse decays but before lysosomal function declines; experimentally prolong lifetime to test this timing dependence

    Possible result

    Possible reduction in absolute growth of altered cells while autophagic benefit persists

    From the recordЭкспериментальное продление времени жизни MYC закроет интервал, а обратимое удаление TFEB перед формированием лизосомной программы устранит сохраняющуюся аутофагическую пользу.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKαMYC. Hypotheses on this target 1MYC
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 8EfferocytosisSensory afferent activity. Hypotheses on this target 7Sensory afferent activityEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairLipid peroxidation. Hypotheses on this target 6Lipid peroxidationProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growthInflammation resolution. Hypotheses on this target 4Inflammation resolutionInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstructionAutophagy. Hypotheses on this target 2Autophagy
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Helping cells clear damaged material could also help altered cells multiply. The unexpected move is to use the different working lifetimes of proteins to separate those effects, restoring nutrients after growth stimulation fades but while cleanup continues. That timing mechanism is a proposal generated by the pipeline, not a measured result.

The proposed mechanism, link by link
  1. A brief exposure is proposed to act through hypusine-modified eukaryotic initiation factor 5A.
  2. That protein-making helper supports production of transcription factor EB.
  3. The same helper supports production of the growth regulator .
  4. promotes formation of cellular cleanup machinery.
  5. After exposure ends, the system is proposed to switch from simultaneous cleanup and growth stimulation to continued cleanup after the extra activity has faded.
  6. Nutrients return during that proposed interval, allowing normal tissue to recycle damaged material while altered cells receive less additional growth stimulation.
  7. Different protein replacement rates are proposed to preserve functional benefit while limiting the absolute growth of altered cells.
A picture for it

One brief signal starts a cleaning crew and a building crew. If the builders stop first, ordinary activity could resume while the cleaners finish their work.

Where the picture breaks: Cells do not contain independent crews with fixed finishing times. Whether cleanup remains active after growth stimulation ends, and whether returning nutrients preserves that separation, are precisely the untested claims.

  1. Master questionstep 01 of 04

    Reproducing useful processes already performed by the body might offer new ways to extend life.

    Rests on: The supplied goal explicitly seeks new substances, combinations or other interventions that reproduce beneficial bodily processes and explains why they might extend life.

    Stated in the chain
  2. Goal pillarstep 02 of 04

    A useful intervention needs a durable margin before its benefits turn into harm.

    Rests on: The goal seeks longer life through beneficial effects; this stage makes maintaining a margin between benefit and harm a requirement of that search.

    Stated in the chain
  3. Gap questionstep 03 of 04

    Changing when nutrients return, tissue repairs itself and immune cells remove other cells might preserve , the delivery and breakdown of cellular material for recycling, while limiting , the relative advantage gained by descendants of particular cells, at the same total exposure.

    Rests on: The preceding stage requires a margin between benefit and harm but does not identify this particular conflict or establish timing as its control.

    Assumption

    The question takes as its working premise that a , an intervention involving the family of small molecules that includes and intended here to reproduce fasting-related effects, offers both a recycling benefit and a risk of favoring altered cells. Neither the preceding stage nor the supplied source excerpts establishes that combined outcome under equal total exposure.

  4. Hypothesisstep 04 of 04

    Cleanup machinery is proposed to keep working after a brief exposure has stopped providing extra growth stimulation. Restoring nutrients during that interval would then preserve cleanup while reducing the absolute increase in altered cells.S1S5

    Rests on: The preceding question supplies the timing problem. Molecular Cell (2019), S1, supports a connection between hypusinated eukaryotic initiation factor 5A, a protein-making helper carrying a chemical modification called hypusine, and production of transcription factor EB, a protein that controls genes for cellular recycling compartments called ; it does not establish the proposed persistence or feeding interval. Cell Death & Disease (2020), S5, supports that helper's role in making , a protein that regulates growth, in colorectal cancer cells; it does not establish different protein lifetimes or a safe timing window. These findings supply individual connections for the proposed mechanism, rather than evidence that its sequence works.

    Supported by literature

What is carried, and what is not. Screened sources speak to three early molecular connections: and the chemical modification of the protein-making helper, its support for transcription factor EB production, and its support for production. (2020), S3, supplies the first connection and reinforces the second in an abstract-only record, without establishing protein lifetimes or a feeding window; together with S1 and S5, these sources support parts of the mechanism, but none establishes the sequence from brief exposure to safer growth, lower tumor risk or longer life.S3S1S5

Where the reasoning is carried by something unstated · 1
  • Gap question. The question takes as its working premise that a , an intervention involving the family of small molecules that includes and intended here to reproduce fasting-related effects, offers both a recycling benefit and a risk of favoring altered cells. Neither the preceding stage nor the supplied source excerpts establishes that combined outcome under equal total exposure.
How a result here could mislead · 3
  • Cleanup that persists after the nominal exposure ends could reflect remaining available, rather than longer-lived protein products. What closes it: The specification requires simultaneous measurement of free . Its time course must be compared with measured protein replacement and cleanup activity so that continued exposure is distinguishable from persistence after exposure.
  • More cleanup compartments could be mistaken for more completed recycling, and a smaller proportion of altered cells could be mistaken for fewer altered cells. What closes it: Measure , the rate at which material passes through and is degraded by the recycling system, alongside absolute numbers of both normal and altered cells. Define the functional benefit and the criterion for a separating interval before evaluating the schedules, while keeping total exposure matched.
  • A timing benefit that survives removal of immune cells and disabling , a secreted enzyme implicated in the competing explanation about suppression of neighboring cells, could be credited entirely to protein lifetimes. The rival involving normal cells starting to copy their genetic material before preparations are complete would still remain. What closes it: Alongside the proposed manipulation that prolongs persistence, measure when normal cells begin copying their genetic material, whether preparation is complete and whether damage follows. Establish whether loss of the interval tracks persistent activity or this competing preparation defect.

What would make this wrong. The central mechanism would fail if cleanup activity and extra activity faded together, leaving no separating interval, or if experimentally verified prolongation of persistence left that separation unchanged. Persistence of the cleanup benefit despite verified removal of transcription factor EB before the cleanup machinery formed would also contradict the proposed route. Failure to preserve functional benefit while reducing absolute altered-cell growth during the measured interval would break the claimed connection between molecular timing and safer tissue recovery.

What it would change. If the mechanism held, the search for life-extending imitations of bodily processes would need to consider how long their protein products remain active, as well as the amount and timing of exposure. The candidate strategy would reproduce a sequence of cleanup followed by recovery, with nutrient restoration timed to measured persistence of cleanup and loss of extra growth stimulation. Results in , laboratory-grown three-dimensional models of intestinal tissue, would still not establish longer life or reduced tumor risk in an intact animal or a human. The record also supplies no definition or measurement for , the internal outcome label the hypothesis claims to stabilize.

Sources read · 10

4 literature searches, 9 full texts, 1 abstract-only; 10 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S1Partly answers it

Polyamines Control eIF5A Hypusination, TFEB Translation, and Autophagy to Reverse B Cell Senescence. · Molecular cell · 2019

“These data suggest that hypusinated eIF5A directly facilitates the synthesis of TFEB partially via the triproline-containing motif.”

Does not settle: Источник не устанавливает роль MYC, различия в продолжительности жизни TFEB, MYC или созданного лизосомного аппарата, временное окно после короткого импульса спермидина, эффекты возобновления питания, избирательное действие на нормальные и изменённые клетки, влияние на SPV_10, продолжительность жизни или опухолевый риск.

S2Background

A surge in endogenous spermidine is essential for rapamycin-induced autophagy and longevity. · Autophagy · 2024

“Activated EIF5A is required for the full autophagy-inducing and longevity-promoting properties of fasting.”

Does not settle: Источник не исследует TFEB, MYC, продолжительность жизни этих белков, временное разделение аутофагии и клонального роста, возобновление питания в предполагаемом временном промежутке, стабилизацию SPV_10 или влияние такого режима на опухолевый риск.

S3Partly answers itAbstract only

Polyamines reverse immune senescence via the translational control of autophagy. · Autophagy · 2020

“Mechanistically, spermidine post-translationally modifies (hypusinates) the translation factor EIF5A. Hypusinated EIF5A specifically regulates the synthesis of the master autophagy and lysosome transcription factor, TFEB (transcription factor EB).”

Does not settle: Источник связывает спермидин, гипусинирование EIF5A и синтез TFEB, но не рассматривает MYC, продолжительность жизни или кинетику обновления белков, краткий импульс воздействия, возобновление питания, различия между нормальными и изменёнными клетками, клональный рост, SPV_10 и опухолевый риск.

S4Contradicts it

Polyamine and EIF5A hypusination downstream of c-Myc confers targeted therapy resistance in BRAF mutant melanoma. · Molecular cancer · 2024

“We also identify that sustained c-Myc levels in vemurafenib-resistant cancer are responsible for elevated polyamine biosynthesis.”

Does not settle: Источник описывает c-Myc как регулятор биосинтеза полиаминов, то есть указывает направление связи, противоположное заявленному. Он не устанавливает влияние гипусинированного eIF5A на образование TFEB или MYC, сроки обновления этих белков, сохранение лизосомной функции после короткого импульса, разделение аутофагии и клонального роста, действие спермидинового миметика, стабилизацию SPV_10, влияние на продолжительность жизни или опухолевый риск.

S5Partly answers it

Blockade of EIF5A hypusination limits colorectal cancer growth by inhibiting MYC elongation. · Cell death & disease · 2020

“Indeed, we demonstrate that EIF5A regulates MYC elongation without affecting its mRNA content or protein stability, by alleviating ribosome stalling at five distinct pausing motifs in MYC CDS.”

Does not settle: The source does not establish TFEB regulation, differential TFEB/MYC protein lifetimes, persistence of lysosomal or autophagic activity after a short spermidine-mimetic pulse, a feeding-dependent temporal window, selective effects on normal versus altered tissue, SPV_10 stabilization, lifespan benefit, or reduced tumor risk from the proposed timing strategy.

S6Background

A role for polyamine regulators in ESC self-renewal. · Cell cycle (Georgetown, Tex.) · 2012

“In this study, AMD1 was shown to promote high levels of MYC, which is an established self-renewal factor and previously demonstrated target of the polyamine pathway.”

Does not settle: The source does not establish that hypusinated EIF5A supports TFEB or MYC translation, compare TFEB and MYC protein lifetimes, test a spermidine-mimetic pulse or nutrient-refeeding window, demonstrate persistent autophagic benefit after growth stimulation ends, assess altered-cell clonal growth or tumor risk, or report effects on SPV_10 or lifespan.

S7Partly answers it

Combined inhibition of polyamine metabolism and eIF5A hypusination suppresses colorectal cancer growth through a converging effect on MYC translation. · Cancer letters · 2023

“We have recently discovered that inhibition of DHPS efficiently suppresses CRC cell growth and intestinal tumorigenesis in mice, by directly inhibiting eIF5A-mediated elongation of MYC at five distinct pausing motifs in MYC coding sequence (CDS) [10].”

Does not settle: The source does not establish TFEB regulation, differential TFEB/MYC protein lifetimes, a post-pulse therapeutic window, continued autophagic recycling after refeeding, selective loss of growth stimulation in altered cells, SPV_10 stabilization, or longevity benefit with reduced tumor risk.

S8Background

Autophagy in the Heart. · Circulation journal : official journal of the Japanese Circulation Society · 2019

“A polyamine, spermidine, is reported to bring about an extension of lifespan and to protect the heart from age-related cardiac dysfunction, both of which are mediated through induction of autophagy.”

Does not settle: The source does not establish an eIF5A–TFEB–MYC mechanism, different protein lifetimes, temporal separation of autophagy from clonal growth, effects of a short spermidine-mimetic pulse followed by refeeding, selective outcomes in normal versus altered cells, SPV_10 stabilization, or reduced tumor risk while preserving longevity benefits.

S9Partly answers it

Reactivation of autophagy by spermidine ameliorates the myopathic defects of collagen VI-null mice. · Autophagy · 2015

“Systemic administration of spermidine in col6a1 −/− mice reactivated autophagy in a dose-dependent manner, leading to a concurrent amelioration of the histological and ultrastructural muscle defects.”

Does not settle: The source does not establish eIF5A-dependent translation of TFEB or MYC, their protein lifetimes, temporal separation of autophagy from clonal growth, effects after nutrient refeeding, SPV_10 stabilization, longevity benefit, tumor risk, or transfer to normal or transformed human tissue.

S10Background

Cardioprotection and lifespan extension by the natural polyamine spermidine. · Nature medicine · 2016

“Oral supplementation of spermidine promotes basal autophagic flux in cardiac tissue, and the direct protective effects of spermidine on the heart appear to require cardiomyocyte autophagy.”

Does not settle: Источник не устанавливает роль гипусинированного eIF5A в образовании TFEB или MYC, сроки обновления этих белков, временное разделение аутофагии и клонального роста, действие короткого импульса миметика, влияние возобновления питания, стабилизацию SPV_10 или снижение опухолевого риска. В исследовании также не выявлено снижения частоты рака у старых мышей C57BL/6, получавших спермидин.

The gap this hypothesis explains

Can timing a polyamine-like treatment preserve cellular recycling benefits without favoring particular cell families at equal total exposure?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Можно ли разделить и при действии , изменяя взаимное время питания, и при одинаковом суммарном воздействии?

What this question is asking

The question asks whether changing a treatment’s timing can separate a helpful effect on cellular recycling from an effect that favors some cell families over others. The treatment is a , a substance intended to imitate effects of compounds called polyamines. The proposed comparison keeps total treatment exposure equal while changing when treatment occurs relative to feeding, tissue rebuilding, and cell removal by the immune system. The question assumes that this treatment produces both a cellular recycling benefit and selection among cell families, but the supplied material does not establish either effect or identify the organism, treatment, or measurements.

What the terms mean
Polyamines
A class of compounds found in cells. The question names this class as the reference for a treatment but specifies no individual compound or particular effect to be imitated.
Polyamine mimetic
A substance intended to imitate some effects of polyamines. The label describes an intended resemblance, not proof that it reproduces every effect of those compounds.
Autophagy
Processes through which cells break down and recycle their own material. An autophagic benefit means a beneficial consequence attributed to those processes; increased recycling alone does not define the benefit, and the supplied material gives no measure of it.
Clone or cell family
A group of cells descended from one starting cell. The question concerns whether treatment favors some such groups over others, without identifying which groups.
Clonal selection
Preferential survival or expansion of particular cell families compared with others. The term describes a change in the cell population and does not by itself establish whether that change is helpful or harmful.
Regeneration
Rebuilding or replacing tissue. The question treats the timing of this process as potentially relevant to the treatment’s effects.
Immune clearance
Removal of cells by the immune system, the body’s system for recognizing and responding to threats. The question does not specify which cells are removed or how the timing of removal is determined.
Cumulative exposure
The total exposure to treatment over the period being compared. Keeping this equal is intended to distinguish timing effects from differences in overall exposure, but the question does not define how that total is calculated.
Physiological processes
Processes through which living bodies function. The broader request concerns imitating such processes to extend life, but it supplies no evidence that this particular treatment would do so.
What the question takes for granted
Premise could not be checked
A produces an autophagic benefit and that might be separated by changing timing relative to feeding, regeneration, and immune clearance at equal cumulative exposure.

The assumption concerns a treatment that imitates polyamines, cellular machinery that breaks down and recycles material, and groups of cells descended from individual starting cells. It assumes the treatment improves recycling while favoring some of those groups, creating two effects whose dependence on timing can be compared. Establishing both effects would give the proposed separation a concrete meaning.

No screened sources were supplied. There is therefore no read evidence establishing either treatment effect, their relationship, or the role of timing; this does not show that the assumption is false.

The same question asked without the part nothing read establishes:

  • At equal total exposure, does changing a polyamine-like treatment’s timing relative to feeding, tissue rebuilding, and immune cell removal change cellular recycling benefits and the relative growth or survival of cell families?
  • Does a polyamine-like treatment produce both beneficial cellular recycling and preferential growth or survival of particular cell families?
What turns on the answer
  • Timing separates the effects At equal total exposure, one schedule would preserve the recycling benefit while reducing or avoiding preferential survival or expansion of particular cell families. Within the question’s framing, the timing of exposure would therefore determine whether these effects occur together; that result alone would not establish longer life.
  • The effects remain linked Schedules that preserve the recycling benefit would also retain selection among cell families. Changing timing would then fail to provide the proposed separation within the conditions compared, and the recycling result would still need to be understood alongside the population change.
  • The assumed pair of effects is absent If the treatment does not produce a recycling benefit or does not favor particular cell families, there would be no demonstrated pair of effects to separate. A difference between schedules would then answer a narrower question about whichever effect actually occurs.
Why it matters

The broader context is whether imitating physiological processes could help extend life. Under the question’s proposed mechanism, treatment would improve recycling within cells while also changing which cell families survive or expand. If timing separated these effects, the recycling benefit would not necessarily require the same change in the cell population. If it did not, treating improved recycling as sufficient evidence of an overall benefit could overlook changes in that population; the supplied material does not establish whether those changes would be harmful or affect lifespan.

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

допускает временное разделение и благодаря разной продолжительности жизни . поддерживает образование регулятора и ростового регулятора . Предполагается, что после короткого импульса созданный через сохраняет функцию дольше, чем ростовой импульс . Если питание возобновляется внутри этого промежутка, нормальная ткань продолжает переработку повреждённых компонентов, а изменённые клетки уже теряют дополнительную стимуляцию роста. Причинный носитель разделения состоит в различной . Такой миметик воспроизводит последовательность физиологической очистки и восстановления, стабилизирует и потенциально сохраняет пользу для продолжительности жизни при ограничении опухолевого риска.

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

После обнаружится интервал, в котором остаётся повышенным, а дополнительная активность уже исчезла. Возобновление питания в этом интервале сохранит функциональную пользу при меньшем абсолютном росте изменённых клеток даже без иммунных клеток и при выключенном . Экспериментальное продление времени жизни закроет интервал, а обратимое удаление перед формированием устранит сохраняющуюся . Если белковые ответы затухают совместно либо изменение времени жизни не меняет разделимость, гипотеза отвергается.

States a measurable outcome; comparing rivals needs more conditions. The prediction specifies observable temporal separation, intervention-dependent outcomes, and explicit rejection conditions. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

, измерение и управляемое изменение позволяют проверить последовательность в . Необходимо одновременно измерять : длительное сохранение препарата само по себе не подтверждает гипотезу о времени жизни .

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

После обнаружится интервал, в котором остаётся повышенным, а дополнительная активность уже исчезла. Возобновление питания в этом интервале сохранит функциональную пользу при меньшем абсолютном росте изменённых клеток даже без иммунных клеток и при выключенном . Экспериментальное продление времени жизни закроет интервал, а обратимое удаление перед формированием устранит сохраняющуюся . Если белковые ответы затухают совместно либо изменение времени жизни не меняет разделимость, гипотеза отвергается.

  • What would separate them

    Immune killing of normal regenerating cells may favor precancerous clone growth predicts: В старых мышах с нормальными и -изменёнными кишечными клетками совпадение , питания и иммунного пика сначала увеличит иммунные контакты и гибель нормальных клеток, затем увеличит абсолютную численность изменённого . Краткая только в этом окне либо удаление соответствующих только у нормальных клеток уменьшит поздний абсолютный рост при сохранении . Перенос на другое окно такого эффекта не даст. Отсутствие преимущественной иммунной гибели нормальных клеток опровергнет центральное звено, даже если изменение расписания окажется полезным.

  • What would separate them

    Altered cells may suppress normal repair through an enzyme above a local abundance threshold predicts: При одинаковом расписании и одинаковой общей знак изменения доли изменённого будет зависеть от его исходной локальной доли. Перестановка фаз питания и удаления даст разные результаты по разные стороны измеренного . в изменённых клетках устранит этот и соответствующее , сохранив нормальных клеток. Если преимущество одинаково при разных долях и сохраняется после выключения , предложенный механизм отвергается.

  • What would separate them

    Premature DNA copying may damage resting cells as they resume growth and favour altered clones predicts: Вредное совпадение фаз даст уменьшение количества связанного с перед первой , затем повреждения ДНК преимущественно в нормальных клетках, вышедших из . Эффект сохранится при выключенном и отсутствии иммунных клеток. Краткое продление подготовительной фазы обратимым воздействием на должно восстановить -7 и уменьшить последующее преимущество изменённого при сохранении . Для подтверждения требуется сопоставить завершённое число делений за весь цикл: простое подавление недостаточно. Если преимущество расписания сохраняется после выравнивания подготовки , это объяснение отвергается.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionStates a measurable outcome; comparing rivals needs more conditionsTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.